Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 00:39 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Stem Cell Recruitment in Osteoporosis Therapy
NCT01656629 · Johns Hopkins University · NA · terminated · last registry update 2020-08-21 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “Inability to analyze collected samples due to no funds.” | – | Registry record, Johns Hopkins University |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against PTH1R within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2021-06-25Also stopped (terminated): University of Aarhus, Zoledronic acid + Teriparatide (NCT01679080)
- 2021-06-10Phase 3 first posted: Norfolk and Norwich University Hospitals NHS Foundation Trust, Teriparatide (NCT04921124)
- 2021-04-21Results posted on the registry: Elizabeth Shane, Denosumab (NCT02049866)
- 2021-04-12Also stopped (withdrawn): Johns Hopkins University, Abaloparatide + Placebo (NCT03708926)
- 2021-02-17Results posted on the registry: Shane Burch, teriparatide + Placebo (NCT01292252)
- 2021-02-11Phase 3 first posted: Saint Petersburg State University, Russia, Teriparatide (NCT04750460)
- 2021-01-22Results posted on the registry: Massachusetts General Hospital, denosumab + teriparatide (NCT02176382)
- 2021-01-08Phase 3 first posted: Ascendis Pharma Bone Diseases A/S, TransCon PTH + Placebo (NCT04701203)
- 2020-12-11Results posted on the registry: Radius Health, Inc., Alendronate (NCT01657162)
- 2020-09-16Results posted on the registry: Post Graduate Institute of Medical Education and Research, Chandigarh, Teriparatide (NCT02023411)
- 2019-12-12Phase 3 first posted: University of East Anglia, Teriparatide (NCT04196855)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision